|
Thank
you for your interest in OPDC. We're happy to answer questions
about our company, and you can also find additional information on
our website by clicking on these topics:
Please note that we cannot provide answers to personal medical questions. To obtain
such answers you should contact your healthcare provider. Also note
that this system is not designed to respond to product
complaints.
For questions/comments regarding
ABILIFY® (aripiprazole) Tablets1,
call (800) 321-1335
For questions/comments regarding PLETAL® (cilostazol)
Tablets2
, call
Otsuka’s
Medical Affairs Department
at (800) 441-6763
toll free
For
questions/comments regarding
ZEGERID
®
(omeprazole/sodium bicarbonate)3
call (858) 778-0887
For
information regarding Otsuka's
Adacolumn clinical trials for
ulcerative colitis or crohn's disease, call (866) 560-5828 or
e-mail adacolumn@robarts.ca
For
information regarding Otsuka's
Polycystic
Kidney Disease
clinical trials,
call (866) 712-5837
We
are not currently enrolling additional patients in
Otsuka's
Hyponatremia
clinical trials,
however, please continue to monitor www.clinicaltrials.gov for
future information
We
are not currently enrolling additional patients in
Otsuka's
Dry
Eye
clinical trials,
however, please continue to monitor www.clinicaltrials.gov for
future information
Otsuka Pharmaceutical Development & Commercialization, Inc.
Princeton, NJ 08540
(609) 452-2922 phone
(609) 452-0794 fax
Rockville, MD 20850
(301) 417-0900 phone (800) 438-6124 toll free
(301) 990-0036 fax
humanresources@otsuka.com or by mail
to:
Human Resources
Otsuka America Pharmaceutical, Inc.
2440 Research Boulevard
Rockville, MD
20850 USA
Debra.Kaufmann@otsuka.com or by mail
to:
Corporate Communications
Otsuka America Pharmaceutical, Inc.
2440 Research Boulevard Rockville, MD
20850 USA
(800) 441-6763
Productinfo@otsuka.com
webmaster@otsuka.com
1 Please see FULL PRODUCT INFORMATION including for ABILIFY.
2 Please see FULL PRODUCT INFORMATION including for PLETAL.
3 Please see FULL PRODUCT INFORMATION for ZEGERID.
|